A Randomized, Double-blind, Four Period Cross-over Comparison of the Effect of Two Doses Lavoltidine, Esomeprazole, and Placebo on 24 Hour Gastric pH and Frequency of Heartburn in Symptomatic GERD Subjects Without Esophageal Erosions
Latest Information Update: 06 Jul 2023
At a glance
- Drugs Esomeprazole (Primary) ; Lavoltidine (Primary) ; Ranitidine (Primary)
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 15 Oct 2008 Actual start date changed from Apr 2006 to May 2006 as reported by Clinicaltrials.gov
- 12 Oct 2008 Trial phase changed from I to II as reported by ClinicalTrials.gov.
- 22 Jun 2007 Status change from recruiting to completed